Virginia Retirement Systems’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$516K Sell
2,800
-1,700
-38% -$370K ﹤0.01% 898
2026
Q2
$1.1M Buy
+4,500
New +$976K 0.01% 724
2025
Q3
– Sell
-2,100
Closed -$219K – 938
2025
Q2
$219K Buy
+2,100
New +$222K ﹤0.01% 889
2020
Q4
– Sell
-3,100
Closed -$221K – 1109
2020
Q3
$221K Buy
+3,100
New +$242K ﹤0.01% 1011
2020
Q1
– Sell
-12,900
Closed -$1.33M – 1090
2019
Q4
$1.33M Sell
12,900
-5,100
-28% -$206K 0.01% 578
2019
Q3
$364K Buy
18,000
+3,300
+22% +$84.8K ﹤0.01% 973
2019
Q2
$379K Buy
+14,700
New +$295K ﹤0.01% 986

Other funds holding AXSM

Virginia Retirement Systems's AXSM Position: Q3 2026 in Review

Virginia Retirement Systems reduced its Axsome Therapeutics (AXSM) stake by 38% in Q3 2026, selling an estimated $370K and leaving 2,800 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Virginia Retirement Systems first reported a position in AXSM in Q2 2019 and has held it in 7 quarters since. The position peaked at $1.33M in Q4 2019. 132 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Virginia Retirement Systems held 2,800 shares of Axsome Therapeutics worth $516K as of Q3 2026.
  • Virginia Retirement Systems sold 1,700 Axsome Therapeutics shares in Q3 2026, an estimated $370K.
  • Axsome Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #898 holding.
  • Virginia Retirement Systems first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 7 quarters since.
  • Virginia Retirement Systems's Axsome Therapeutics position peaked at $1.33M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.